The effect of danazol on the human female urethra.

Zentralblatt fur Gynakologie · 1981 · vol. 103(22) , pp. 1344–7 · PMID:7200308 · W2409020708
article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-11

Danazol treatment of six women for eight weeks caused a moderate decrease in resting urethral pressure and reduced stress transmission but did not jeopardize urinary continence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The urethral pressure profile was recorded, at rest and under stress, from six women in fertile age, before and at the end of an eight-week treatment during which the probands received daily doses of 600 mg of Danazol. Only moderate decrease in maximum urethral pressure was established, at rest, though oestrogen production was markedly reduced. Reduction in transmission of intra-abdominal pressure to the urethra was registered under stress, but urethral closure pressure remained positive in all subjects. Bladder pressure and functional length of the urethra were almost unaffected. Danazol treatment does not seem to jeopardize maintenance of urinary continence in young females.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Pregnadienes Urethra Adult Danazol Danazol Endometriosis Endometriosis Female Humans Leiomyoma Leiomyoma Male Middle Aged Pregnadienes Pressure Urethra Urinary Bladder Urinary Bladder

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-05-10T11:16:35.852252+00:00
pubmed
last seen: 2026-05-13T22:10:10.897782+00:00
License: CC0 · commercial use OK